Molecular mutation may be more common among African Americans with late onset Alzheimer’s, provide a possible focus for early diagnosis and targeted treatments
Here’s how the work of a team of researchers three decades ago led to the first-ever FDA-approved drug for treating the deadly disease known as Duchenne...